Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP677382.RAVeKz7metV5fOQXxxZdLI79goq2SV9GZuAMjYhwnuE8o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP677382.RAVeKz7metV5fOQXxxZdLI79goq2SV9GZuAMjYhwnuE8o130_assertion type Assertion NP677382.RAVeKz7metV5fOQXxxZdLI79goq2SV9GZuAMjYhwnuE8o130_head.
- NP677382.RAVeKz7metV5fOQXxxZdLI79goq2SV9GZuAMjYhwnuE8o130_assertion description "[Taken together with prior studies demonstrating a role for Fas/APO-1 and Fas ligand, respectively, in tumor target cell killing by cytotoxic T-lymphocytes, production of soluble Fas/APO-1 might have significant implications in malignant disease pathogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP677382.RAVeKz7metV5fOQXxxZdLI79goq2SV9GZuAMjYhwnuE8o130_provenance.
- NP677382.RAVeKz7metV5fOQXxxZdLI79goq2SV9GZuAMjYhwnuE8o130_assertion evidence source_evidence_literature NP677382.RAVeKz7metV5fOQXxxZdLI79goq2SV9GZuAMjYhwnuE8o130_provenance.
- NP677382.RAVeKz7metV5fOQXxxZdLI79goq2SV9GZuAMjYhwnuE8o130_assertion SIO_000772 7542559 NP677382.RAVeKz7metV5fOQXxxZdLI79goq2SV9GZuAMjYhwnuE8o130_provenance.
- NP677382.RAVeKz7metV5fOQXxxZdLI79goq2SV9GZuAMjYhwnuE8o130_assertion wasDerivedFrom befree-20140225 NP677382.RAVeKz7metV5fOQXxxZdLI79goq2SV9GZuAMjYhwnuE8o130_provenance.
- NP677382.RAVeKz7metV5fOQXxxZdLI79goq2SV9GZuAMjYhwnuE8o130_assertion wasGeneratedBy ECO_0000203 NP677382.RAVeKz7metV5fOQXxxZdLI79goq2SV9GZuAMjYhwnuE8o130_provenance.